Paper35141015
5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.
Zhuang Y and 11 others. Am J Cancer Res, 2022. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. 5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity. Papers, record 35141015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35141015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27620987 | Microtubule destabilising agents: far more than just antimitotic anticancer drugs. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27620987 | PubMed |
| 2 | 26562752 | Control of microtubule organization and dynamics: two ends in the limelight. | Nat Rev Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26562752 | PubMed |
| 3 | 26537178 | Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis. | Eur J Cancer Care (Engl) | 2017 | https://conductscience.org/library/papers/26537178 | PubMed |
| 4 | 10071301 | Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10071301 | PubMed |
| 5 | 14593726 | Tubulin and microtubules as targets for anticancer drugs. | Prog Cell Cycle Res | 2003 | https://conductscience.org/library/papers/14593726 | PubMed |
| 6 | 18783207 | Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. | J Med Chem | 2008 | https://conductscience.org/library/papers/18783207 | PubMed |
| 7 | 2009540 | Mechanism of inhibition of cell proliferation by Vinca alkaloids. | Cancer Res | 1991 | https://conductscience.org/library/papers/2009540 | PubMed |
| 8 | 18329278 | Peripheral nerve damage associated with administration of taxanes in patients with cancer. | Crit Rev Oncol Hematol | 2008 | https://conductscience.org/library/papers/18329278 | PubMed |
| 9 | 15948296 | Review: tubulin function, action of antitubulin drugs, and new drug development. | Cancer Invest | 2005 | https://conductscience.org/library/papers/15948296 | PubMed |
| 10 | 12700769 | Dynamics and mechanics of the microtubule plus end. | Nature | 2003 | https://conductscience.org/library/papers/12700769 | PubMed |
| 11 | 25673085 | Triple-negative breast cancer in African-American women: disparities versus biology. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/25673085 | PubMed |
| 12 | 19303656 | HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD. | J Hepatol | 2009 | https://conductscience.org/library/papers/19303656 | PubMed |
| 13 | 16445613 | A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. | Int J Gynecol Cancer | 2006 | https://conductscience.org/library/papers/16445613 | PubMed |
| 14 | 27153208 | Design of a novel microtubule targeted peptide vesicle for delivering different anticancer drugs. | Chem Commun (Camb) | 2016 | https://conductscience.org/library/papers/27153208 | PubMed |
| 15 | 26177395 | Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors. | Chem Biol Drug Des | 2015 | https://conductscience.org/library/papers/26177395 | PubMed |
| 16 | 10590893 | Chemotherapeutic neuropathy. | Curr Opin Neurol | 1999 | https://conductscience.org/library/papers/10590893 | PubMed |
| 17 | 15714588 | Much anticipated--the bioactive conformation of epothilone and its binding to tubulin. | Angew Chem Int Ed Engl | 2005 | https://conductscience.org/library/papers/15714588 | PubMed |
| 18 | 28766222 | Breast Cancer Disparities: Socioeconomic Factors versus Biology. | Ann Surg Oncol | 2017 | https://conductscience.org/library/papers/28766222 | PubMed |
| 19 | 18347795 | Preclinical discovery of ixabepilone, a highly active antineoplastic agent. | Cancer Chemother Pharmacol | 2008 | https://conductscience.org/library/papers/18347795 | PubMed |
| 20 | 25385183 | The contribution of αβ-tubulin curvature to microtubule dynamics. | J Cell Biol | 2014 | https://conductscience.org/library/papers/25385183 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42816471 | Targeting the HPGDS-PGD2 axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42816471 | PubMed |
| 36119827 | Snail induces dormancy in disseminated luminal type A breast cancer through Src inhibition. | Am J Cancer Res | 2022 | https://conductscience.org/library/papers/36119827 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PGP | 283871 | PubTator's text mining | https://conductscience.org/library/genes/283871 | NCBI Gene |
| TUBA1B | 10376 | PubTator's text mining | https://conductscience.org/library/genes/10376 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35141015
GET https://conductscience.org/api/papers/v1/35141015/references?page=2